Irving Kass

1.2k total citations
59 papers, 826 citations indexed

About

Irving Kass is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Epidemiology. According to data from OpenAlex, Irving Kass has authored 59 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 13 papers in Surgery and 12 papers in Epidemiology. Recurrent topics in Irving Kass's work include Chronic Obstructive Pulmonary Disease (COPD) Research (17 papers), Tuberculosis Research and Epidemiology (11 papers) and Respiratory Support and Mechanisms (9 papers). Irving Kass is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (17 papers), Tuberculosis Research and Epidemiology (11 papers) and Respiratory Support and Mechanisms (9 papers). Irving Kass collaborates with scholars based in United States, Czechia and France. Irving Kass's co-authors include A. James Fix, David M. Daughton, Kashinath D. Patil, Noé Zamel, Mo Ghafouri, Michael Hölzer, Jerald R. Schenken, Alan Jackson, G Middlebrook and Gian Franco Gensini and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Investigation.

In The Last Decade

Irving Kass

53 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irving Kass United States 18 347 248 129 120 114 59 826
M W McNicol United Kingdom 23 412 1.2× 272 1.1× 176 1.4× 171 1.4× 226 2.0× 69 1.3k
H Berger United States 18 470 1.4× 116 0.5× 183 1.4× 194 1.6× 282 2.5× 87 1.1k
Lawrence V. Perlman United States 12 114 0.3× 164 0.7× 80 0.6× 63 0.5× 100 0.9× 22 1000
Kent A. Kirchner United States 20 100 0.3× 258 1.0× 131 1.0× 90 0.8× 133 1.2× 43 1.1k
Gerald R. Kerby United States 14 464 1.3× 252 1.0× 100 0.8× 44 0.4× 146 1.3× 30 793
R.M. Pandey India 14 112 0.3× 182 0.7× 101 0.8× 45 0.4× 101 0.9× 26 741
Hülya Taşkapan Türkiye 18 154 0.4× 75 0.3× 193 1.5× 99 0.8× 151 1.3× 81 987
T Vargish United States 18 159 0.5× 94 0.4× 114 0.9× 26 0.2× 466 4.1× 57 1.4k
C. Almeida Spain 18 537 1.5× 920 3.7× 217 1.7× 153 1.3× 158 1.4× 78 1.6k
Kathleen McCarroll United States 18 69 0.2× 96 0.4× 201 1.6× 54 0.5× 198 1.7× 36 846

Countries citing papers authored by Irving Kass

Since Specialization
Citations

This map shows the geographic impact of Irving Kass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irving Kass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irving Kass more than expected).

Fields of papers citing papers by Irving Kass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irving Kass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irving Kass. The network helps show where Irving Kass may publish in the future.

Co-authorship network of co-authors of Irving Kass

This figure shows the co-authorship network connecting the top 25 collaborators of Irving Kass. A scholar is included among the top collaborators of Irving Kass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irving Kass. Irving Kass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kass, Irving, et al.. (2015). Lack of Correlation between Clinical Background and Pulmonary Function Tests in Patients with Chronic Obstructive Pulmonary Diseases. American Review of Respiratory Disease.
2.
Repsher, Lawrence H., John A. Anderson, Robert K. Bush, et al.. (1984). Assessment of Tachyphylaxis following Prolonged Therapy of Asthma with Inhaled Albuterol Aerosol. CHEST Journal. 85(1). 34–38. 69 indexed citations
3.
Daughton, David M., et al.. (1982). Maximum oxygen consumption and the ADAPT quality-of-life scale.. PubMed. 63(12). 620–2. 95 indexed citations
4.
Fix, A. James, et al.. (1980). Emotional, Intellectual and Physiological Predictors of Vocational Outcome of Pulmonary Rehabilitation Patients. Psychological Reports. 46(2). 379–382. 5 indexed citations
5.
Kass, Irving, et al.. (1980). Bitolterol Mesylate (WIN 32784) Aerosol. CHEST Journal. 78(2). 283–287. 17 indexed citations
6.
Daughton, David M., et al.. (1979). Physiological-intellectual components of rehabilitation success in patients with chronic obstructive pulmonary disease (COPD). Journal of Chronic Diseases. 32(5). 405–409. 6 indexed citations
7.
Kass, Irving, et al.. (1977). Beclomethasone Dipropionate Aerosol in the Treatment of Steroid-Dependent Asthmatic Patients. CHEST Journal. 71(6). 703–707. 17 indexed citations
8.
Kass, Irving, et al.. (1976). Beclomethasone Dipropionate Aerosol in the Treatment of Steroid-Dependent Asthma. CHEST Journal. 70(3). 345–350. 15 indexed citations
9.
10.
11.
Kass, Irving, et al.. (1972). Correlation of the Ventilation and Perfusion Aspects of Chronic Obstructive Pulmonary Disease: A Review of 100 Cases. CHEST Journal. 61(5). 459–464. 4 indexed citations
12.
Elliott, R., et al.. (1971). A Perspective on the Role of Cromolyn Sodium as an Antiasthmatic Agent. CHEST Journal. 60(3). 210–213. 17 indexed citations
13.
Kass, Irving & Noé Zamel. (1970). Simplified Bedside Evaluation of Respiratory Insufficiency. Postgraduate Medicine. 47(3). 78–83. 1 indexed citations
14.
Kass, Irving. (1966). KANAMYCIN IN THE THERAPY OF PULMONARY TUBERCULOSIS IN THE UNITED STATES*. Annals of the New York Academy of Sciences. 132(2). 892–900. 4 indexed citations
15.
Kass, Irving. (1965). COMPARISON OF PAS, THIACETAZONE OR 4-4 DIISOAMYLOXYTHIOSEMICARBANILIDE WITH STREPTOMYCIN AND ISONIAZID IN PREVIOUSLY UNTREATED PATIENTS WITH PULMONARY TUBERCULOSIS.. PubMed. 46. 178–87. 1 indexed citations
16.
Kass, Irving, et al.. (1961). THROMBOEMBOLIC COMPLICATIONS FOLLOWING INSERTION OF THE HUFNAGEL PROSTHESIS. Journal of Thoracic and Cardiovascular Surgery. 41(4). 492–497. 5 indexed citations
17.
Russell, William F., et al.. (1959). COMBINED DRUG TREATMENT OF TUBERCULOSIS. III. CLINICAL APPLICATION OF THE PRINCIPLES OF APPROPRIATE AND ADEQUATE CHEMOTHERAPY TO THE TREATMENT OF PULMONARY TUBERCULOSIS. Journal of Clinical Investigation. 38(8). 1366–1375. 19 indexed citations
18.
Kass, Irving, et al.. (1956). THE USE OF METRAZOL AS A MOOD CONDITIONING DRUG. The Journal of Nervous and Mental Disease. 123(1). 57–64. 4 indexed citations
19.
Kass, Irving, et al.. (1954). REPORT OF A CASE OF PURPURA ANNULARIS TELANGIECTODES (MAJOCCHI'S DISEASE) AND ITS TREATMENT WITH CORTISONE. Annals of Internal Medicine. 41(2). 349–357. 2 indexed citations
20.
Kass, Irving, et al.. (1952). Treatment of Broncho-Pulmonary Moniliasis by Dye Inhalation. Diseases of the Chest. 21(2). 205–209. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M W McNicol Breakdown of academic impact, for papers by H Berger Breakdown of academic impact, for papers by Lawrence V. Perlman Breakdown of academic impact, for papers by Kent A. Kirchner Breakdown of academic impact, for papers by Gerald R. Kerby Breakdown of academic impact, for papers by R.M. Pandey Breakdown of academic impact, for papers by Hülya Taşkapan Breakdown of academic impact, for papers by T Vargish Breakdown of academic impact, for papers by C. Almeida Breakdown of academic impact, for papers by Kathleen McCarroll
Rankless by CCL
2026